Invenomic Capital Management LP Bristol Myers Squibb CO Transaction History

Invenomic Capital Management LP

  • $1.99 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $24 Million - $26.8 Million
414,551 Added 74.87%
968,234 $56.2 Million
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $1.39 Million - $1.54 Million
-21,802 Reduced 3.79%
553,683 $35.4 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $37.8 Million - $42.9 Million
575,485 New
575,485 $39.9 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email